SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-382414
Filing Date
2017-12-29
Accepted
2017-12-29 06:31:02
Documents
2
Period of Report
2017-12-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d489039d8k.htm 8-K 14388
2 EX-99.1 d489039dex991.htm EX-99.1 19265
  Complete submission text file 0001193125-17-382414.txt   34794
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 171279756
SIC: 2836 Biological Products, (No Diagnostic Substances)